Fig. 1

Pharmacodynamic evaluation diagram (A) and changes of key inflammatory indicators in serum (B: myeloperoxidase, MPO; C: serum amyloid A, SAA; D: C-reactive protein, CRP; E: thymic stromal lymphoprotein, TSLP; n = 10; * P < 0.05, *** P < 0.001, compared with the RSV group; ### P < 0.001, compared with the control group; data presented as mean ± standard error of mean)